Summit Investment Advisors »

Tevogen Bio Hldgs shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $789 2.1k 0.37
2024-06-30 $1.6k 2.1k 0.72

More positions owned by Summit Investment Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Etf (IVV)
Amazon (AMZN)
Vanguard Europe Pacific ETF (VEA)
Broadcom (AVGO)
Vanguard S&p 500 Etf idx (VOO)
iShares Lehman Aggregate Bond (AGG)
Spdr Ser Tr Etf (ONEV)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
iShares S&P 500 Growth Index (IVW)
Vanguard Total Bond Market ETF (BND)
iShares S&P 500 Value Index (IVE)

View all positions for Summit Investment Advisors

Top funds holding Tevogen Bio Hldgs

Portland Global Advisors
Polar Securities
Cantor Fitzgerald, L. P.
Geode Capital Management
BlackRock
BlackRock
Vanguard Group
New York State Common Retirement Fund
Northern Trust
State Street Corporation
Charles Schwab Investment Management
Barclays
AQR Capital Management
Jpmorgan Chase & Co
Alpine Partners VI

View all funds holding Tevogen Bio Hldgs